Generalized anxiety disorder (GAD) is a chronic and highly prevalent disord
er in the adult population, yet it remains a relatively poorly understood c
ondition. Clinicians may be familiar with the symptoms of enduring excessiv
e worrying, anxiety, and hypervigilance that are characteristic of GAD. but
may not necessarily recognize that these are usually symptoms of a distinc
t psychiatric disorder. Despite changes in diagnostic criteria, estimates o
f prevalence for GAD are remarkably consistent across epidemiologic studies
. Lifetime prevalence in the general population is estimated at 5% (DSM-III
and/or DSM-III-R criteria), with rates as high as 10% among women aged 40
years and above, and cross-sectional rates among primary care attenders are
about 8%, making GAD the most prevalent anxiety disorder in primary care.
The age at onset of GAD differs from that of other anxiety disorders: preva
lence rates are low in adolescents and young adults but increase substantia
lly with age. Females are at greater risk than males, and the disorder is c
orrelated with being unemployed or a housewife or having a chronic medical
illness. GAD is frequently associated with comorbid depression and other an
xiety and somatoform disorders. Significant CAD-specific disability occurs
even when comorbidity is not present.